Access the full text.
Sign up today, get DeepDyve free for 14 days.
C. Fazi, L. Scarfò, L. Pecciarini, F. Cottini, Antonis Dagklis, A. Janus, A. Talarico, C. Scielzo, C. Sala, D. Toniolo, F. Caligaris‐cappio, P. Ghia (2011)
General population low-count CLL-like MBL persists over time without clinical progression, although carrying the same cytogenetic abnormalities of CLL.Blood, 118 25
V. Morrison (2009)
Infectious complications in patients with chronic lymphocytic leukemia: pathogenesis, spectrum of infection, and approaches to prophylaxis.Clinical lymphoma & myeloma, 9 5
I. Criado, A. Rodríguez‐Caballero, M. Gutiérrez, C. Pedreira, M. Alcoceba, Wendy Nieto, Cristina Teodosio, P. Bárcena, Alfonso Romero, Paulino Fernández-Navarro, Marcos González, J. Almeida, A. Órfão (2018)
Low-count monoclonal B-cell lymphocytosis persists after seven years of follow up and is associated with a poorer outcomeHaematologica, 103
J. Moreira, K Rabe, J. Cerhan, N Kay, J Wilson, T. Call, J. Leis, D. Jelinek, S. Schwager, D. Bowen, C. Hanson, S. Slager, T. Shanafelt (2013)
Infectious complications among individuals with clinical monoclonal B-cell lymphocytosis (MBL): a cohort study of newly diagnosed cases compared to controlsLeukemia, 27
I. Criado, S. Muñoz-Criado, A. Rodríguez‐Caballero, Wendy Nieto, Alfonso Romero, Paulino Fernández-Navarro, M. Alcoceba, Teresa Contreras, Marcos González, A. Órfão, J. Almeida (2017)
Host virus and pneumococcus-specific immune responses in high-count monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia: implications for disease progressionHaematologica, 102
D. Casabonne, J. Almeida, Wendy Nieto, Alfonso Romero, Paulino Fernández-Navarro, A. Rodríguez‐Caballero, S. Muñoz-Criado, M. Díaz, Y. Benavente, S. Sanjosé, A. Órfão (2012)
Common Infectious Agents and Monoclonal B-Cell Lymphocytosis: A Cross-Sectional Epidemiological Study among Healthy AdultsPLoS ONE, 7
Gonzalo Blanco, A. Vardi, A. Puiggros, Andrea Gómez-Llonín, M. Muro, M. Rodríguez-Rivera, E. Stalika, E. Abella, E. Gimeno, Manuela López-Sánchez, A. Senín, X. Calvo, P. Abrisqueta, F. Bosch, A. Ferrer, K. Stamatopoulos, B. Espinet (2018)
Restricted T cell receptor repertoire in CLL-like monoclonal B cell lymphocytosis and early stage CLLOncoImmunology, 7
G. D’Arena, G. Rossi, M. Minervini, L. Savino, F. D’Auria, L. Laurenti, M. Principe, S. Deaglio, A. Biagi, L. Martino, V. Feo, T. Statuto, P. Musto, G. Poeta (2011)
Circulating Regulatory T Cells in “Clinical” Monoclonal B-Cell LymphocytosisInternational Journal of Immunopathology and Pharmacology, 24
I. Criado, E. Blanco, A. Rodríguez‐Caballero, M. Alcoceba, Teresa Contreras, M. Gutiérrez, Alfonso Romero, Paulino Fernández-Navarro, Marcos González, F. Solano, C. Gómez, M. Pérez‐Andrés, J. Dongen, J. Almeida, A. Órfão (2018)
Residual normal B-cell profiles in monoclonal B-cell lymphocytosis versus chronic lymphocytic leukemiaLeukemia, 32
T. Shanafelt, P. Ghia, M. Lanasa, O. Landgren, A. Rawstron (2010)
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical managementLeukemia, 24
A. Rawstron, T. Shanafelt, M. Lanasa, O. Landgren, C. Hanson, A. Órfão, P. Hillmen, P. Ghia (2010)
Different biology and clinical outcome according to the absolute numbers of clonal B‐cells in monoclonal B‐cell lymphocytosis (MBL)Cytometry Part B: Clinical Cytometry, 78B
J. Olson, E. Ryu, Kiley Johnson, B. Koenig, K. Maschke, Jody Morrisette, M. Liebow, P. Takahashi, Z. Fredericksen, Ruchi Sharma, K. Anderson, M. Hathcock, J. Carnahan, Jyotishman Pathak, N. Lindor, T. Beebe, S. Thibodeau, J. Cerhan (2013)
The Mayo Clinic Biobank: a building block for individualized medicine.Mayo Clinic proceedings, 88 9
A. Rawstron, Michael Green, A. Kuzmicki, B. Kennedy, J. Fenton, P. Evans, S. O'Connor, S. Richards, G. Morgan, A. Jack, P. Hillmen (2002)
Monoclonal B lymphocytes with the characteristics of "indolent" chronic lymphocytic leukemia are present in 3.5% of adults with normal blood counts.Blood, 100 2
A. Ramsay, A. Johnson, Abigail Lee, Güllü Gorgün, Rifca Dieu, W. Blum, J. Byrd, J. Gribben (2008)
Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.The Journal of clinical investigation, 118 7
Leukemia (2021) 35:239–244 https://doi.org/10.1038/s41375-020-0799-8 LETTER Chronic lymphocytic leukemia Risk of serious infection among individuals with and without low count monoclonal B-cell lymphocytosis (MBL) 1 2 2 2 2 2 ● ● ● ● ● ● Tait D. Shanafelt Neil E. Kay Sameer A. Parikh Sara J. Achenbach Connie E. Lesnick Curtis A. Hanson 2 2 2 2 2 2 ● ● ● ● ● ● Geffen Kleinstern Janet E. Olson Aaron D. Norman Kari G. Rabe Susan M. Schwager Timothy G. Call Susan L. Slager Received: 7 October 2019 / Revised: 27 February 2020 / Accepted: 9 March 2020 / Published online: 18 March 2020 © Springer Nature Limited 2020 To the Editor: the approval of the Mayo Clinic IRB, we screened partici- pating individuals from Olmsted County (the county in Monoclonal B-cell lymphocytosis (MBL), the precursor state which Mayo Clinic is located), Minnesota, who were 40 to chronic lymphocytic leukemia (CLL), is one of the most years of age or older, no prior history of hematologic common premalignant conditions in humans [1, 2]. MBL is malignancy, and who had stored PBMC (samples from subdivided into low count (LC) MBL and high count (HC) 7/14/2009 to 3/4/2016). Data on
Leukemia – Springer Journals
Published: Mar 18, 2020
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.